Kevin P. Kerns

Array ( [id] => 7712259 [patent_doc_number] => 08093218 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-10 [patent_title] => 'Peptide derived from vascular endothelial growth factor receptor-1 binding integrin α5β1 having proangiogenic activity' [patent_app_type] => utility [patent_app_number] => 12/375775 [patent_app_country] => US [patent_app_date] => 2007-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5473 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/093/08093218.pdf [firstpage_image] =>[orig_patent_app_number] => 12375775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 274364 [patent_doc_number] => 07560530 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-07-14 [patent_title] => 'IL-33 receptor' [patent_app_type] => utility [patent_app_number] => 11/779755 [patent_app_country] => US [patent_app_date] => 2007-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 19 [patent_no_of_words] => 8692 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/560/07560530.pdf [firstpage_image] =>[orig_patent_app_number] => 11779755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5521477 [patent_doc_number] => 20090029458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Chicken leukemia inhibitory factor (LIF) and gene thereof' [patent_app_type] => utility [patent_app_number] => 11/826581 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3426 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20090029458.pdf [firstpage_image] =>[orig_patent_app_number] => 11826581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 141680 [patent_doc_number] => 07691589 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-06 [patent_title] => 'Method of preventing differentiation of a chicken differentiable cell using chicken leukemia inhibitory factor (LIF)' [patent_app_type] => utility [patent_app_number] => 11/826578 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3441 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/691/07691589.pdf [firstpage_image] =>[orig_patent_app_number] => 11826578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7597497 [patent_doc_number] => 07619080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-17 [patent_title] => 'Oligonucleotides of a chicken leukemia inhibitory factor (LIF) gene' [patent_app_type] => utility [patent_app_number] => 11/826577 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3443 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/619/07619080.pdf [firstpage_image] =>[orig_patent_app_number] => 11826577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 588293 [patent_doc_number] => 07435548 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Methods for producing ex vivo models for inflammatory disease and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/879066 [patent_app_country] => US [patent_app_date] => 2007-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8183 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 232 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435548.pdf [firstpage_image] =>[orig_patent_app_number] => 11879066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4926984 [patent_doc_number] => 20080166347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Human antibodies specific for interleukin 15 (IL-15)' [patent_app_type] => utility [patent_app_number] => 11/827306 [patent_app_country] => US [patent_app_date] => 2007-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 31274 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166347.pdf [firstpage_image] =>[orig_patent_app_number] => 11827306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 247207 [patent_doc_number] => 07585961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-08 [patent_title] => 'Nucleic acid encoding human antibodies specific for interleukin 15 (IL-15)' [patent_app_type] => utility [patent_app_number] => 11/827195 [patent_app_country] => US [patent_app_date] => 2007-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 36 [patent_no_of_words] => 31274 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/585/07585961.pdf [firstpage_image] =>[orig_patent_app_number] => 11827195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4944002 [patent_doc_number] => 20080081327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-03 [patent_title] => 'METHOD FOR USING DIVISION ARRESTED CELLS IN SCREENING ASSAYS' [patent_app_type] => utility [patent_app_number] => 11/775708 [patent_app_country] => US [patent_app_date] => 2007-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3434 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20080081327.pdf [firstpage_image] =>[orig_patent_app_number] => 11775708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 582403 [patent_doc_number] => 07442371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-28 [patent_title] => 'Recombinant human albumin-erythropoietin fusion proteins with long-lasting biological effects' [patent_app_type] => utility [patent_app_number] => 11/825686 [patent_app_country] => US [patent_app_date] => 2007-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 10 [patent_no_of_words] => 16220 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/442/07442371.pdf [firstpage_image] =>[orig_patent_app_number] => 11825686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4746164 [patent_doc_number] => 20080090766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Preventive or therapeutic agents for diseases including interleukin-18 inhibitor as an active ingredient' [patent_app_type] => utility [patent_app_number] => 11/825646 [patent_app_country] => US [patent_app_date] => 2007-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6578 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20080090766.pdf [firstpage_image] =>[orig_patent_app_number] => 11825646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10869819 [patent_doc_number] => 08895012 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'sgp130/Fc dimers' [patent_app_type] => utility [patent_app_number] => 12/307003 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5638 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12307003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4824861 [patent_doc_number] => 20080124307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Method for promoting immunotherapy' [patent_app_type] => utility [patent_app_number] => 11/819147 [patent_app_country] => US [patent_app_date] => 2007-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9782 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124307.pdf [firstpage_image] =>[orig_patent_app_number] => 11819147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5464416 [patent_doc_number] => 20090324616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'DIFFERENTIAL CYTOKINE EXPRESSION IN HUMAN CANCER' [patent_app_type] => utility [patent_app_number] => 12/306070 [patent_app_country] => US [patent_app_date] => 2007-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 6943 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324616.pdf [firstpage_image] =>[orig_patent_app_number] => 12306070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 352480 [patent_doc_number] => 07491500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-17 [patent_title] => 'Mammalian cytokine; related reagents' [patent_app_type] => utility [patent_app_number] => 11/764674 [patent_app_country] => US [patent_app_date] => 2007-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29247 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/491/07491500.pdf [firstpage_image] =>[orig_patent_app_number] => 11764674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4785017 [patent_doc_number] => 20080138346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Antibodies to a chemokine expressed in inflamed adenoid' [patent_app_type] => utility [patent_app_number] => 11/806846 [patent_app_country] => US [patent_app_date] => 2007-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9629 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138346.pdf [firstpage_image] =>[orig_patent_app_number] => 11806846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4710584 [patent_doc_number] => 20080299110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Methods and kits for diagnosing and treating acute joint injury' [patent_app_type] => utility [patent_app_number] => 11/809551 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14986 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299110.pdf [firstpage_image] =>[orig_patent_app_number] => 11809551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5010466 [patent_doc_number] => 20070280945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'High affinity antibodies to human IL-6 receptor' [patent_app_type] => utility [patent_app_number] => 11/809482 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8880 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20070280945.pdf [firstpage_image] =>[orig_patent_app_number] => 11809482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7811447 [patent_doc_number] => 08133978 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Humanised anti-interleukin-18 antibody' [patent_app_type] => utility [patent_app_number] => 11/752707 [patent_app_country] => US [patent_app_date] => 2007-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16490 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133978.pdf [firstpage_image] =>[orig_patent_app_number] => 11752707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 256518 [patent_doc_number] => 07576193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-18 [patent_title] => 'Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation' [patent_app_type] => utility [patent_app_number] => 11/804895 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 9820 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/576/07576193.pdf [firstpage_image] =>[orig_patent_app_number] => 11804895 [rel_patent_id] =>[rel_patent_doc_number] =>)